Research indexJournal article
Current Comment
JAMA1 Mar 1941
NobleIDark:/48914/w1/20260525/79C0F2B8DOI10.1001/jama.1941.02820090040013
Current Comment
JAMA · 1941 · Subscription
NobleIDark:/48914/w1/20260525/79C0F2B8DOI10.1001/jama.1941.02820090040013
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
DANGEROUS DRUGS The Federal Food, Drug and Cosmetic Act prohibits, among other matters, the introduction or delivery for introduction into interstate or foreign commerce or commerce within the District of Columbia or the territories, or the manufacture within the District of Columbia or one of the territories, of a drug that is misbranded. Section 502 (j) provides that a drug shall be deemed to be misbranded if it is dangerous to health when used in the dosage or with the frequency or duration prescribed, recommended or suggested in its labeling. The Food and Drug Administration has informally declared that there are a number of drugs which are in fact dangerous if consumed other than on expert advice and under constant supervision. There are other drugs, however, which may safely be distributed to the public for consumption in small doses under labels bearing adequate directions for use and adequate warnings against